Skip to content
Screener

Zevra Therapeutics, Inc. ZVRA Book value per share

Book value per share at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$32.51+6.3%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$2.86-286%
RFL
Rafael Holdings, Inc.RFL
$1.47-53.9%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$20.31+1,888%
XER
Xeris Biopharma Holdings, Inc.XERS
-$0.06+53.5%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$5.67+69.7%

Other financials

Income statement

See full
Revenue$39.7M+53.3%
Gross profit$38.1M+182%
Operating income$16.8M+124%
Net income$8.8M-88.3%
EPS (diluted)$0.14-88.4%

Balance sheet

See full
Cash & equivalents$145.3M+205%
Total debt$1.5M-97.6%
Total equity$217.7M+85.7%
Total assets$302.7M+18.1%

Cash flow

See full
Operating cash flow$17.0M+573%
CapEx$217.0K+1.9%
Free cash flow$16.8M+541%

Valuation

See full
Market cap$705.48M+12.4%
Enterprise value$561.65M-12.6%
P/E12.1×-225×
P/S5.2×-4.9×

Profitability

See full
Gross margin95.5%+23.5pp
Operating margin-103.9%-43.0pp
Net margin42.8%+38.6pp
FCF margin-75%-30.5pp

Returns & leverage

See full
Return on equity34.8%+31.3pp
Debt / equity-0.5×
Current ratio5.2×-2.7×

Where this comes from

Calculated from Zevra Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 5:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001434647-26-000068

FAQ

What is Zevra Therapeutics, Inc.'s book value per share?
Zevra Therapeutics, Inc. (ZVRA) reported book value per share of $3.55 in Q2 2026.
How has Zevra Therapeutics, Inc.'s book value per share changed year-over-year?
Zevra Therapeutics, Inc.'s book value per share increased by 70.5% year-over-year, from $2.08 to $3.55.
What is the long-term trend for Zevra Therapeutics, Inc.'s book value per share?
Over 3 years (2020 to 2025), Zevra Therapeutics, Inc.'s book value per share has grown at a -45.5% compound annual growth rate (CAGR), from -$16.68 to $2.70.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ask your AI about Zevra Therapeutics, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude